TGQUANT
LIVE

Serial Number

79346602

Owner

TissueGnostics GmbH

Attorney

Ralph Locher

Filing Date

Jan 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TGQUANT Trademark

Serial Number: 79346602 • Registration: 7141381

TGQUANT is a trademark filed by TissueGnostics GmbH on January 14, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TissueGnostics GmbH (5 trademarks)

Taborstraße 10/2/8

Entity Type: 27

Trademark Details

Filing Date

January 14, 2022

Registration Date

August 22, 2023

Published for Opposition

June 6, 2023

Goods & Services

Recorded analysis software for tissue samples stained with color reagents

Diagnostic reagents for medical use; diagnostic agents for medical use; diagnostic chemical reagents for medical use; diagnostic reagents for in vitro use in the field of medicine; in vitro diagnostic preparations for medical use; diagnostic test strips for medical use; diagnostic reagents, for medical use, for sale in kit form; staining preparations being chemical reagents for medical use; staining kits comprised of chemical reagents for medical use; specific staining kits comprised of chemical reagents for medical use; quantitative staining kits comprised of chemical reagents for medical use; histological staining kits comprised of fluorescent marked anti-bodies for application with tissues samples of human or animal tissue for medical use; staining kits for staining tissue sections comprised of chemical reagents for medical use

Chemicals for use in industry and science; biological preparations for use in industry and science; diagnostic reagents for scientific use; diagnostic preparations for scientific use; chemical diagnostic reagents for scientific use; indicators being chemicals for scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; in vitro diagnostic preparations for scientific use; diagnostic test strips for scientific use; diagnostic reagents, other than for medical use, for sale in kit form; staining chemicals for scientific use; staining kits comprised of chemicals for scientific use; specific staining kits comprised of chemicals for scientific use; quantitative staining kits comprised of chemicals for scientific use; histological staining kits comprised of chemicals for scientific use; staining kits for staining tissue sections comprised of chemicals for scientific use

Diagnostic apparatus and diagnostic measuring apparatus for medical use, namely, for analyzing medical samples; analytical apparatus for histological use in the field of medicine, namely, for analyzing tissue samples

Biological and medical research and analysis; histological research services; histological development services; histological laboratory services; histological analysis; consultancy services in the field of histology research; research and development in the field of histology; research and development of microscopy-based diagnostic methods based on the analysis of tissue and cell cultures; analysis of human tissues for medical research; development of hardware and analytic software in the field of histology for scientific research and medical and clinical diagnostics

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 27, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 27, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 22, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 22, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Jun 6, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 17, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 17, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 2, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 12, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 12, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 1, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 31, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 9, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2022 REPR